Hong Kong-listed biotech stocks jumped on Thursday. TYK Medicines surged over 15%, while Sirnaomics climbed more than 13%. CanSino Biologics rose more than 7%, Everest Medicines and Akeso advanced about 5%.
The rally comes amid renewed investor interest in the healthcare sector, driven by expectations of policy support and ongoing innovation momentum.